We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+1.07%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$260B
AUM Growth
+$123M
Cap. Flow
-$889M
Cap. Flow %
-0.34%
Top 10 Hldgs %
14.45%
Holding
8,655
New
737
Increased
4,061
Reduced
2,893
Closed
594

Sector Composition

Rank Sector Weight
1 Technology 9.47%
2 Financials 6.72%
3 Healthcare 6.27%
4 Consumer Discretionary 5.76%
5 Industrials 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KDNY
6276
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$42K ﹤0.01%
7,998
+4,685
+141% +$31.1K
NWHM
6277
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$42K ﹤0.01%
9,601
+544
+6% +$2.23K
CEFL
6278
DELISTED
ETRACS Monthly Pay 2xLeveraged Closed-End Fund ETN
CEFL
$42K ﹤0.01%
2,958
+313
+12% +$4.46K
APLT
6279
DELISTED
Applied Therapeutics
APLT
$41K ﹤0.01%
3,743
+1,599
+75% +$15.1K
APYX icon
6280
Apyx Medical
APYX
$176M
$41K ﹤0.01%
6,000
-2,000
-25% -$14.2K
EFO icon
6281
ProShares Ultra MSCI EAFE
EFO
$31.4M
$41K ﹤0.01%
1,113
-279
-20% -$10.3K
FEMB icon
6282
First Trust Emerging Markets Local Currency Bond ETF
FEMB
$360M
$41K ﹤0.01%
+1,089
New +$42.1K
FTRI icon
6283
First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF
FTRI
$125M
$41K ﹤0.01%
3,555
+828
+30% +$9.58K
GME icon
6284
GameStop
GME
$8.62B
$41K ﹤0.01%
29,920
-4,023,924
-99% -$4.35M
GORO icon
6285
Goldgroup Mining Inc.
GORO
$164M
$41K ﹤0.01%
13,468
+2,708
+25% +$9.5K
IAG icon
6286
IAMGOLD
IAG
$8.55B
$41K ﹤0.01%
11,923
-136,655
-92% -$491K
KEQU icon
6287
Kewaunee Scientific
KEQU
$107M
$41K ﹤0.01%
2,628
-1,224
-32% -$20.6K
LPG icon
6288
Dorian LPG
LPG
$1.97B
$41K ﹤0.01%
3,970
-4,831
-55% -$47.3K
RETL icon
6289
Direxion Daily Retail Bull 3X ETF
RETL
$31.4M
$41K ﹤0.01%
4,513
+73
+2% +$642
VERU icon
6290
Veru
VERU
$38M
$41K ﹤0.01%
1,867
-112
-6% -$2.33K
WATT icon
6291
CALL
Energous
WATT
$98.2M
$41K ﹤0.01%
21
WEAT icon
6292
Teucrium Wheat Fund
WEAT
$295M
$41K ﹤0.01%
1,572
-643
-29% -$17K
JNCE
6293
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$41K ﹤0.01%
12,480
+9,549
+326% +$38.2K
VALX
6294
DELISTED
Validea Market Legends ETF
VALX
$41K ﹤0.01%
1,658
+400
+32% +$9.93K
DYB
6295
DELISTED
WisdomTree Dynamic Bearish U.S. Equity Fund
DYB
$41K ﹤0.01%
1,865
+155
+9% +$3.41K
BZM
6296
DELISTED
BlackRock Maryland Municipal Bond Trust
BZM
$41K ﹤0.01%
2,820
-513
-15% -$7.45K
AUTL
6297
Autolus Therapeutics
AUTL
$519M
$40K ﹤0.01%
3,235
-3
-0.1% -$40
BRID icon
6298
Bridgford Foods
BRID
$57.5M
$40K ﹤0.01%
1,328
+1,016
+326% +$35.2K
FCVT icon
6299
First Trust SSI Strategic Convertible Securities ETF
FCVT
$103M
$40K ﹤0.01%
1,288
+975
+312% +$30.8K
IFS icon
6300
Intercorp Financial Services
IFS
$6.64B
$40K ﹤0.01%
+961
New +$39.4K

Similar funds

UBS Group's Q3 2019 Portfolio in Review

As of Q3 2019, UBS Group held 8,655 positions worth $260B, up 0.05% from $260B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q3 2019 filing shows 737 new, 4,061 increased, 2,893 reduced and 594 closed positions. Its largest new stake was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.92B.

By sector, the portfolio is most concentrated in Technology at 9.5% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q3 2019 buy was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M.
  • UBS Group added most to iShares US Treasury Bond ETF in Q3 2019, an estimated $469M increase.
  • UBS Group's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.92B.
  • UBS Group fully exited OAKTREE CAPITAL GROUP, LLC in Q3 2019, selling an estimated $172M.
  • UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q3 2019.
  • UBS Group opened 737 new positions and closed 594 in Q3 2019.
  • UBS Group's portfolio value rose 0.05% quarter-over-quarter to $260B.

Based on UBS Group's 13F filing for Q3 2019, filed 14 Nov 2019.